Green Fresh Biotechnology Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Green Fresh Biotechnology.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals earnings growth | 35.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Green Future Food Hydrocolloid Marine Science Company Limited's (HKG:1084) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30
Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Might Not Be As Mispriced As It Looks
Sep 05Should Shareholders Worry About Green Future Food Hydrocolloid Marine Science Company Limited's (HKG:1084) CEO Compensation Package?
May 31Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Aiming To Keep Up Its Impressive Returns
Apr 19Estimating The Fair Value Of Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084)
Feb 19Investors Shouldn't Overlook The Favourable Returns On Capital At Green Future Food Hydrocolloid Marine Science (HKG:1084)
Dec 18Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Increasing Its Dividend To HK$0.03
Jun 04Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Increasing Its Dividend To HK$0.03
Apr 03Should You Be Adding Green Future Food Hydrocolloid Marine Science (HKG:1084) To Your Watchlist Today?
Mar 10Green Future Food Hydrocolloid Marine Science (HKG:1084) Has Announced That It Will Be Increasing Its Dividend To HK$0.02
Sep 02Be Wary Of Green Future Food Hydrocolloid Marine Science (HKG:1084) And Its Returns On Capital
Sep 01Here's What's Concerning About Green Future Food Hydrocolloid Marine Science's (HKG:1084) Returns On Capital
May 25Green Future Food Hydrocolloid Marine Science (HKG:1084) Has A Pretty Healthy Balance Sheet
Apr 29Green Future Food Hydrocolloid Marine Science (HKG:1084) Has Re-Affirmed Its Dividend Of HK$0.025
Apr 04Green Future Food Hydrocolloid Marine Science (HKG:1084) Will Pay A Smaller Dividend Than Last Year
Sep 02Green Future Food Hydrocolloid Marine Science (HKG:1084) Could Be Struggling To Allocate Capital
Apr 10Is Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) A Good Fit For Your Dividend Portfolio?
Mar 06Green Future Food Hydrocolloid Marine Science's(HKG:1084) Share Price Is Down 11% Over The Past Year.
Feb 08How Much Of Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Do Insiders Own?
Jan 18We Think Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Taking Some Risk With Its Debt
Dec 28
Could The Market Be Wrong About Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Given Its Attractive Financial Prospects?
Dec 10Should You Be Impressed By Green Future Food Hydrocolloid Marine Science's (HKG:1084) Returns on Capital?
Nov 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Fresh Biotechnology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 989 | 62 | 81 | 129 | N/A |
| 9/30/2024 | 1,020 | -13 | 121 | 159 | N/A |
| 6/30/2024 | 1,050 | -87 | 161 | 189 | N/A |
| 3/31/2024 | 1,112 | -86 | 123 | 143 | N/A |
| 12/31/2023 | 1,174 | -85 | 85 | 97 | N/A |
| 9/30/2023 | 1,262 | 17 | 10 | 30 | N/A |
| 6/30/2023 | 1,350 | 120 | -64 | -36 | N/A |
| 3/31/2023 | 1,380 | 160 | -67 | -31 | N/A |
| 12/31/2022 | 1,411 | 199 | -70 | -26 | N/A |
| 9/30/2022 | 1,330 | 183 | -26 | 14 | N/A |
| 6/30/2022 | 1,215 | 164 | 13 | 50 | N/A |
| 3/31/2022 | 1,063 | 122 | 8 | 57 | N/A |
| 12/31/2021 | 948 | 84 | 7 | 70 | N/A |
| 9/30/2021 | 872 | 71 | -23 | 52 | N/A |
| 6/30/2021 | 784 | 56 | -53 | 32 | N/A |
| 3/31/2021 | 767 | 57 | -35 | 34 | N/A |
| 12/31/2020 | 739 | 58 | -16 | 35 | N/A |
| 9/30/2020 | 821 | 71 | -28 | 14 | N/A |
| 6/30/2020 | 908 | 85 | -40 | -8 | N/A |
| 3/31/2020 | 929 | 86 | -68 | -36 | N/A |
| 12/31/2019 | 887 | 83 | -57 | -18 | N/A |
| 3/31/2019 | 864 | 90 | -18 | 28 | N/A |
| 12/31/2018 | 876 | 82 | -17 | 34 | N/A |
| 12/31/2017 | 551 | 77 | N/A | 92 | N/A |
| 12/31/2016 | 319 | 32 | N/A | 64 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1084's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if 1084's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1084's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1084's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1084's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1084's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/30 09:50 |
| End of Day Share Price | 2025/07/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Fresh Biotechnology Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.